Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Topical glucocorticosteroids inhibit allergic skin inflammation but are ineffective in impeding the formation and expansion of resident memory T cells

ABSTRACT: Tissue-resident memory T (TRM) cells are detrimental in numerous chronic inflammatory diseases, including allergic contact dermatitis (ACD), in which they contribute to the chronicity and severity of the disease. We assessed the impact of a standard glucocorticosteroid treatment, triamcinolone acetonide (TA), on the formation, maintenance and reactivation of epidermal TRM cells in ACD.

ORGANISM(S): Mus musculus

PROVIDER: GSE216725 | GEO | 2023/08/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	GSE216725_INS-MV-b001_HGYYWBGXH_S1_R2.ReadCounts.tsv.gz	Tabular
	GSE216725_INS-MV-b003_HDMERGEDL_S8_R2.ReadCount.tsv.gz	Tabular
	GSE216725_INS_MV_b001_barcode.tsv.gz	Tabular

Items per page:

1 - 4 of 4

Similar Datasets

Effect of glucocorticoid chemical structure and receptor potency on human trabecular meshwork cells

Project description:Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells. Gene expression changes of human trabecular meshwork cells, TM 86 and TM 93, due to treatment with dexamethasone (Dex), fluocinolone acetonide (FA), and triamcinolone acetonide (TA).

2010-02-15 | GSE16643 | GEO

Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma.

Project description:Sputum airway cells transcriptome from 19 asthmatics from the Severe Asthma Research Program at baseline and 6-8 weeks follow-up after a 40mg dose of intramuscular corticosteroid triamcinolone acetonide.

2022-06-09 | GSE184433 | GEO

Transcriptome landscape of HeLa response upon triamcinolone acetonide

Project description:Transcriptome landscape of HeLa response upon triamcinolone acetonide

| PRJNA475732 | ENA

Topical glucocorticosteroids inhibit allergic skin inflammation but are ineffective in impeding the formation and expansion of resident memory T cells

Project description:Topical glucocorticosteroids inhibit allergic skin inflammation but are ineffective in impeding the formation and expansion of resident memory T cells

| PRJNA895049 | ENA

Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling [RNA-seq]

Project description:Skin scarring impairs function and aesthetics. Current therapies show limited efficacy and cause iatrogenic dermal disruption (e.g., triamcinolone acetonide, a first-line corticosteroid for keloids), with topical medications demonstrating inferior outcomes. Through transcriptome-guided evaluation, we develop FR-1 (fibrosis-reversal compound 1), a small molecule that reverses fibrosis in vitro by inhibiting fibroblast proliferation, suppressing α-SMA, and remodeling the ECM via collagen downregulation and MMP1 induction. In a murine linear excisional wound model, daily topical FR-1 application progressively reduces scar area. Notably, unlike triamcinolone acetonide, FR-1 avoids skin atrophy and hair follicle damage. Comprehensive safety evaluations, druggability and skin permeation assessments, and studies utilizing patient-derived keloid ex vivo explants and in vivo xenografts demonstrate its translational potential. Mechanistically, FR-1 induces mitochondrial uncoupling, lowering ATP levels in profibrotic myofibroblasts. Other uncouplers similarly attenuate fibrosis. This work identifies a topical small molecule that attenuates scarring, highlighting the therapeutic potential of mitochondrial uncouplers in resolving fibrosis.

2026-05-18 | GSE303487 | GEO

Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling [DRUG-seq2]

2026-05-18 | GSE303486 | GEO

RNA-seq of synovial membranes from a preclinical model of post-traumatic knee osteoarthritis to evaluate the effects of corticosteroid treatment

Project description:Yorkshire pigs received untreated unilateral ACL transection through a medial arthrotomy (INJ, n=6), transection with immediate injection of 20mg triamcinolone acetonide (TRI, n=6) or no surgery (CON, n=6). Synovial membranes were harvested two weeks after the injury in the lateral knee joint compartment. The whole biopsy was homogenised for RNA extraction. The objective of the experiment was to test if intraarticular corticosteroid injection mitigates injury-induced synovitis and collagen degradation after anterior cruciate ligament transection and to characterize the synovial response using the described perturbations in combination with a functional genomics approach.

2016-01-29 | E-MTAB-4294 | biostudies-arrayexpress

Distinct immune responses and pruritic mechanisms in oxazolone- and urushiol- induced ACD (Allergic contact dermatitis) models.

Project description:The mechanisms underlying pruritus and skin inflammation of poison ivy ACD remain poorly understood,due to limited clinical data and animal studies. Most of the mechanistic understanding of ACD is based upon animal models using experimental allergens not present in the environment, such as oxazolone,DNFB or SADBE . Recently, it has become evident that different allergens elicit widely divergent immune responses in both human and animals, suggesting these models may not be representative of environmental forms of ACD . Given the high incidence and public health impact of poison ivy-induced ACD, it is necessary to establish and characterize a clinically relevant animal model using the actual allergen urushiol. In this study we applied transcriptome microarray to evaluate the cutaneous immune response in urushiol ACD model.

2019-05-31 | GSE131963 | GEO

Transcriptional Profile in Allergic Contact Dermatitis to Methylisothiazolinone

Project description:This study aimed to investigate the signaling pathways induced by MI in the skin test of individuals with MI-sensitized ACD, comparing them to healthy controls. Individuals initially testing positive only for MI were recruited at the Contact Dermatitis Clinic at Hospital das Clínicas of São Paulo, re-exposed to MI or saline, and biopsied 48 hours after exposure. Negative controls for the patch test were also exposed to MI and saline for comparison. Histopathological and transcriptomic (RNAseq) analyses identified two groups among the ACD patients: Group A (GA), with more pronounced histopathological features such as spongiosis and microvesicles, and Group B (GB), which showed milder reactions and absence of spongiosis. In GA, a total of 1588 genes were upregulated and 2090 downregulated in response to MI, compared to GB. These differentially expressed genes (DEGs) were associated with inflammation and neurological signaling, such as IL-24, IL-9, IL-13, and NTRK1, while IL-37 and IL-18 were downregulated. Similarly, GA compared to the MI-negative ACD group showed 1169 upregulated and 321 downregulated genes. DEG validation in GA through qPCR confirmed increased expression of NTRK1, IL-9, IL-6, IL-13, and CXCL8, with a reduction in IL-18. Protein analysis of IL-24 and IL-9 revealed higher expression in the dermal layer of GA. These results indicate distinct transcriptional profiles in MI-sensitized individuals, despite positive patch tests in all cases. The observed heterogeneity, not previously described in ACD, points to new potential therapeutic targets, such as IL-9, IL-37, and NTRK1. Furthermore, the study suggests that inflammatory and neurological cytokines, such as IL-9 and NTRK1, play key roles in the pathogenesis of ACD.

2025-10-14 | GSE305246 | GEO

Gene expression of hypertrophic scar fibroblasts treated with glucocorticoids under mechanical stretch environment

Project description:After disruption of the skin, fibroblasts along wound edges are constantly exposed to high levels of stress, resulting in increased collagen synthesis and decreased apoptosis. Emerge evidences shows that, the hypertrophic scars tissue fibrosis phenomena are original from the intrinsic cellular mechanical stretch. Traditional glucocorticoids on hypertrophic scarring have been performed for 30 years, utilizing for their anti-inflammatory, anti-allergenic and immunomodulatory effects and for their well-established, pro-apoptotic effects on hematological malignancies. To explore effects of glucocorticoid triamcinolone acetonide for responses to mechanical stress in hypertrophic scars fibroblasts (HSFB), we performed microarrays to explore the differential gene expression.

2020-05-28 | GSE151240 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data